Public Health Groups Alert New York to Counterfeit HIV Medications

August 12th, 2025 7:00 AM
By: Newsworthy Staff

Public health organizations have filed a complaint in New York over allegations of counterfeit HIV medication being dispensed, posing a severe risk to patients and public health.

Public Health Groups Alert New York to Counterfeit HIV Medications

The Partnership for Safe Medicines and ADAP Advocacy Association have raised concerns over the alleged distribution of counterfeit HIV medication by City Plus Care Pharmacy Inc., operating as Heal The World Pharmacy, in Queens, New York. The complaint highlights the sale of fake Biktarvy, a crucial HIV treatment, which was found in packaging so convincing it suggests a potential widespread threat to public health. This situation underscores the critical importance of vigilance in the drug supply chain to prevent such dangerous breaches.

Shabbir Safdar, Executive Director of the Partnership for Safe Medicines, emphasized the gravity of the situation, stating that the allegations point to a significant failure in the drug supply chain that could endanger many lives. The incident brings to light the essential role of the Drug Supply Chain Security Act in safeguarding against such violations. Authentic HIV medications are vital for keeping the virus undetectable and untransmissible, a cornerstone of modern HIV treatment and prevention strategies. Counterfeit medications, however, can lead to viral resistance and the reactivation of the virus, undoing years of progress in HIV care.

Brandon M. Macsata, CEO of ADAP Advocacy Association, described the distribution of counterfeit HIV medications as a profound betrayal of trust for the HIV community. The difference between genuine and counterfeit medication can mean the difference between health and severe, life-threatening complications for individuals living with HIV. The complaint calls for immediate regulatory action, including inspections of the pharmacy's facilities and a review of its purchasing records to ensure compliance with federal and state laws.

The advocacy groups are urging for any adverse findings to be referred to the New York Attorney General's Office and the FDA's Office of Drug Security and Office of Criminal Investigations. This case serves as a stark reminder of the ongoing challenges in ensuring the integrity of the drug supply chain and the need for constant vigilance to protect public health. For more information on the efforts to combat counterfeit medications, visit https://www.safemedicines.org.

Source Statement

This news article relied primarily on a press release disributed by 24-7 Press Release. You can read the source press release here,

blockchain registration record for the source press release.
;